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Enteroaggregative, enteropathogenic, and enterotoxigenic Escherichia coli contribute
significantly to the burden of diarrheal infections particularly in developing countries.
Antibiotic resistance is increasingly common among bacterial pathogens including
pathogenic E. coli. We assessed the relationship between pathogenic E. coli carriage
and resistance to six antibiotics in E. coli isolated from young children in rural
Tanzania. We surveyed temporal stability in antibiotic resistance in 2492 E. coli isolated
from fecal samples obtained from young children in rural Tanzania collected over a
6 months period. Approximately half of the 377 children sampled were exposed to
an azithromycin mass treatment program for trachoma control and half resided in
control villages. Children were sampled at baseline, 1-, 3-, and 6 months following
azithromycin treatment. We compared resistance to six antibiotics in pathogenic
and non-pathogenic strains at the population level, within fecal specimens, and
within individuals over time using chi-square tests, paired odds ratios, and logistic
regression, respectively. Resistance to ampicillin and trimethoprim/sulfamethoxazole
was highly prevalent (>65%). Resistance to 5 of 6 antibiotics tested and multi-
drug resistance occurred more frequently in pathogenic isolates (p ≤ 0.001) within
fecal specimens and overall. Azithromycin mass treatment exposure was significantly
associated with increased odds of carriage of isolates resistant to erythromycin (OR
3.64, p < 0.001) and trimethoprim/sulfamethoxazole (OR 1.60, p < 0.05). Pathogenic
isolates were approximately twice as likely to be resistant to erythromycin, ampicillin,
or trimethoprim/sulfamethoxazole compared to non-pathogenic isolates from the same
fecal specimen. The potential linkage between resistance and virulence in E. coli
suggests hygiene and sanitation interventions aimed at reducing disease burden could
play a role in controlling transmission of antibiotic resistance.
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INTRODUCTION
Diarrhea is estimated to be a leading cause of death globally
among children under 5 years of age (Global Burden of Disease
Pediatrics Collaboration et al., 2016). Approximately half of these
deaths occur in sub-Saharan Africa. Although great strides have
been made in reducing mortality, due in part to implementation
of oral rehydration therapy and appropriate feeding practices
during illness, enteric infections are still a significant cause of
morbidity worldwide (Fischer Walker et al., 2012). The burden
is heaviest on pre-school age children who suffer growth faltering
and delayed cognitive development (Niehaus et al., 2002; Lorntz
et al., 2006).
Collectively, diarrheagenic Escherichia coli (DEC) are among
the most the most frequently identified causes of both acute
and moderate-to-severe diarrhea in both community and clinical
settings in low income countries (Kotloff et al., 2013; Platts-
Mills et al., 2015). DEC are identified by specific virulence
factors capable of causing a broad array of gastrointestinal
illness. Enteroaggregative E. coli (EAEC), enteropathogenic E. coli
(EPEC), and enterotoxigenic E. coli (ETEC) are responsible for
the majority of DEC diarrheal infections in Tanzania (Vargas
et al., 2004; Moyo et al., 2007; Platts-Mills et al., 2015).
Antibiotic resistant enteric pathogens are increasingly
recognized in Africa (Okeke et al., 2007). Resistance prevalence
among DEC isolates varies widely between sampling locations,
but high levels of resistance to older, first-line antibiotics such
as penicillins, and trimethoprim-sulfmethoxazole are common
(Vila et al., 1999; Bii et al., 2005; Okeke et al., 2007; Moyo et al.,
2011). Multi-drug resistance is rapidly becoming the norm as
transmissible genetic elements, including plasmids and integrons
contain multigene cassettes including genes encoding resistance
to different antibiotic classes (Tellevik et al., 2007; Ajiboye et al.,
2009). Resistance is also common in ubiquitous non-pathogenic
E. coli; surveys of non-pathogenic E. coli have identified similar
trends of highly prevalent resistance to older antibiotics (Nys
et al., 2004; Djie-Maletz et al., 2008).
Relatively few studies have examined the duration of
resistance in commensal flora within individuals. A study
of adults visiting general practitioners in Germany found
that over a 14 days period, resistance levels were stable in
those not taking antibiotics, patients receiving beta-lactams
showed a transient increase in resistance to ampicillin,
doxycycline, and amoxicillin/clavulanic acid, and those taking
doxycycline, cotrimoxazole and fluoroquinolones showed
more sustained increases in resistance levels (Raum et al.,
2008). A year long study of elderly residents in a long-term
care facility found the median duration of colonization
with multidrug-resistant E. coli was 178 days and co-
colonization with other multidrug resistant gram negative
species was common (O’Fallon et al., 2009). Karami et al.
(2008) followed the colonization dynamics of ampicillin-
resistant E. coli in infants; they found that resistant strains
were able to become well established in the microbiota, persist
as well as susceptible strains, and maintain colonization
over a 1 year period even in the absence of direct selective
pressure.
Two studies in developing country settings have also
demonstrated sustained carriage of resistant commensal flora.
Persistent shedding for 7 weeks or longer of ampicillin,
trimethoprim or tetracycline resistant E. coli was highly prevalent
in a 13-week study of healthy Mexican children under 2 years of
age (Calva et al., 1996). A study in Tanzania of trimethoprim-
sulfamethoxazole (SXT) prophylaxis for HIV-infected adults
found the odds of carriage of SXT-resistant E. coli were
significantly increased at weeks 1, 2, and 4 compared to baseline
(Morpeth et al., 2008).
We investigated the relationship between DEC carriage and
resistance to six antibiotics in E. coli isolated from young
children in rural Tanzania half of whom were exposed to mass
drug treatment with azithromycin (MDA) in the context of a
trachoma elimination program. We previously showed that MDA
exposure was associated with increased carriage of azithromycin-
resistant E. coli in the 6 months following treatment (Seidman
et al., 2014). Here we report on the concordance of resistance
phenotypes between pathogenic and non-pathogenic isolates
within fecal specimens and temporal stability of resistance status
within individuals. We also assessed the impact of exposure to
antibiotics (MDA or therapeutic) on the subsequent carriage of
resistance to antibiotics of the same or different class.
MATERIALS AND METHODS
Study Population
This study was nested within the PRET+ study, a longitudinal
cohort study of the ancillary benefits of mass treatment with
azithromycin for trachoma elimination (Coles et al., 2011, 2012).
PRET+ was conducted in eight villages in Kongwa District,
Tanzania during January–July 2009. Four villages received MDA
as part of a trachoma control program. For ethical reasons,
villages in the same geographic area with trachoma rates below
the intervention threshold were selected as controls. The sub-
cohort sampled in this study was drawn from both intervention
and control villages. Household enumeration occurred during a
census in December 2008; households with at least one resident
<5 years of age were eligible. In each village, one child <5 was
randomly selected for each of 130 randomly selected households
for the PRET+ cohort. Children <3 years were eligible for the
E. coli sub-cohort. A total of 40 children in each village attending
the baseline survey were selected for the E. coli sub-cohort.
Ethical Review and Consent Procedures
The PRET+ study and the nested E. coli study were approved
by the Committee for Human Subjects Research of the Johns
Hopkins School of Medicine and the Tanzanian National
Institute for Medical Research. Prior to the initiation of the
PRET+ study, meetings were held with community leaders to
explain the goals of the study and the collection protocol. Selected
participants were invited to attend the baseline survey in January
2009. Upon arrival at the survey, participants were asked to
provide their consent to be in the PRET+ cohort. Participants
were asked to sign a written consent form (translated into
Swahili) detailing PRET+ study procedures. The content of the
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consent form was also verbally communicated to all participants
by study personnel trained to administer consent. Literate
participants signed the consent form; illiterate participants
indicated consent by providing a thumbprint. A parent or
caregiver provided consent on behalf of each child in the PRET+.
After proceeding through the questionnaire/specimen collection
stations of the survey, parents/caregivers of children eligible to
be in the E. coli cohort had the goals of the E. coli study explained
and provided verbal consent. Subjects in the both the PRET+ and
E. coli cohorts were allowed to refuse participation at any time
during the 6 months PRET+ study without penalty.
Data and Specimen Collection
Sequential cross-sectional surveys to assess prevalence of
diarrheal and other symptoms were conducted at baseline (2 days
prior to MDA in the intervention communities), and 1-, 3-,
and 6-months post-MDA. The MDA regimen consisted of a
single dose of azithromycin (20 mg/kg) administered to all village
residents except children<6 months of age and pregnant women.
During surveys, mothers/caregivers of children in the PRET+
cohort were asked about presence of diarrheal symptoms (defined
as ≥3 loose or watery stools in a 24-h period). Rectal swabs
were collected from E. coli sub-cohort children during cross-
sectional surveys. Swabs were placed immediately into Cary-Blair
and stored at 4◦C once they reached the study office.
Households were visited twice weekly to ascertain incidence of
diarrheal and other symptoms via a standardized questionnaire.
Diarrheal stool samples were collected from all children in the
PRET+ cohort reporting symptoms during household illness
surveillance visits, regardless of whether they were in the E. coli
sub-cohort sampled during the cross-sectional surveys. Diarrheal
stool collection occurred during the first 4 months of the
study period. Symptomatic children in all study villages were
treated with amoxicillin for acute respiratory and ear infections
and chloramphenicol for bloody diarrhea. Rectal swabs and
diarrheal stool specimens were transported to the Kongwa
District Hospital laboratory for isolation and archiving of E. coli
and then shipped to Johns Hopkins University, USA for further
analysis.
Medical dispensaries and shops were surveyed regarding
locally available antibiotics: penicillin/penicillin derivatives were
available in seven villages; cotrimoxazole and erythromycin in 5;
chloramphenicol in 4 and ciprofloxacin in 3. Other antibiotics
that were available included metronidazole (four villages),
doxycycline (three villages) and ceftriaxone (one village).
Laboratory Methods
Fecal specimens were streaked on MacConkey agar (Difco) and
grown overnight at 37◦C. E. coli were presumptively identified on
the basis of lactose fermentation (LF) and colony morphology.
Three LF-positive colonies were inoculated into nutrient agar
stabs and grown overnight at 37◦C followed by storage at
room temperature. Isolates were considered E. coli if LF-positive,
indole-positive (DMACA Indole Reagent droppers, BD), and
citrate-negative (Simmons citrate agar slants, BD). E. coli isolates
were inoculated into Luria broth, grown overnight at 37◦C with
shaking, then frozen at−80◦C with 10% glycerol.
Escherichia coli isolates were tested for susceptibility to
ampicillin (AMP) (10 µg), amoxicillin-clavulanic acid (AMC)
(20/10 µg), chloramphenicol (CHL) (30 µg), ciprofloxacin
(CIP) (5 µg), erythromycin (ERY) (15 µg), and trimethoprim-
sulfamethoxazole (SXT) (1.25/23.75 µg) (BBL Sensi-Discs, BD)
using the disk diffusion method on Mueller-Hinton agar (Difco)
(Bauer et al., 1966). Zone diameters (ZD) were measured in
millimeters. Isolates were classified as susceptible or resistant
according to CLSI guidelines (intermediate zones were classified
resistant) (Clinical Laboratory Standards Insitute, 2008). Since
there are no guidelines for macrolide susceptibility breakpoints
for E. coli, a conservative definition was used whereby an isolate
was classified as ERY resistant only if there was no growth
inhibition (i.e., ZD = 0 mm) (Seidman et al., 2014). Multi-drug
resistance was defined as resistance to ≥3 antibiotics. E. coli
ATCC 25922, Staphylococcus aureus ATCC 25923, and S. aureus
29213 were used for quality control testing of antibiotic reagents.
Diarrheagenic E. coli strains were identified using a multiplex
polymerase chain reaction (PCR) assay with primers to detect the
genes eltB and estA for ETEC, eae and bfpA for EPEC, aaiC and
aatA for EAEC (Supplementary Table S1) (Lüscher and Altwegg,
1994; Schmidt et al., 1995; Oswald et al., 2000; Nguyen et al., 2005;
Boisen et al., 2008; Taniuchi et al., 2012). Initial reactions were
conducted on pools of isolates from the same fecal specimen. All
isolates from negative pools were classified as non-pathogenic;
PCR was repeated on individual isolates from positive pools to
distinguish pathotypes for each isolate in the pool. Approximately
10 µl of frozen culture was suspended in 50 µl of sterile water
then boiled for 10 min; 3 µl of the supernatant was used as
the template. The assay was conducted in a 20 µl reaction
containing 3 µl of template, 20 µM of each primer, 2.5 µl
of 10X Thermopol Buffer (with 2 mM MgCl2) (New England
Biolabs), 2 µl 10 mM dNTP mix (Fermentas), 0.25 µl Taq DNA
polymerase (NEB), and 7.37 µl molecular grade water. Thermal
conditions were as follows: initial denaturation at 96◦C for 4min,
35 cycles of denaturation at 95◦C for 20 s, annealing at 57◦C
for 20 s, elongation at 72◦C for 1 min, and final extension at
72◦C for 7 min. Reactions were performed in 96-well plates in an
Eppendorf Mastercycler Gradient PCR machine. Electrophoresis
and UV translumination were used to separate and visualize PCR
products [2% agarose gel in TBE buffer + ethidium bromide
(1 µg/ml)]. All runs included positive and negative controls.
Pathogenic isolates were classified as follows: ETEC: LT+ and/or
ST+; EPEC: eae+ or eae+/bfpA+; EAEC: aaiC+ and/or aatA+.
ETEC H10407, EPEC 2348/11 and EAEC 042 strains were used
as positive controls (PCR protocol and control strains courtesy of
J.P. Nataro).
Statistical Analysis
We used binary susceptible/resistant classification to calculate the
proportion of isolates resistant to each individual antibiotic and
to determine the frequency of co-resistance patterns. Differences
in pathogenic detection in symptomatic and asymptomatic fecal
specimens as well as differences in antibiotic resistance frequency
among pathogenic and non-pathogenic isolates were compared
using chi-squared tests. We compared the resistance status of
pathogenic and non-pathogenic isolates within those individual
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fecal samples where≥1 isolate was pathogenic and≥1 isolate was
non-pathogenic. We used 1000 bootstrapped samples randomly
selected (with replacement) from the isolate pairs (such that each
fecal sample contributed only one isolate pair to the test set) to
calculate the distribution of paired odds ratios and McNemar’s
test statistics for each antibiotic.
We assessed the within-person temporal relationship between
DEC carriage and resistance status using first order Markov
models to quantify the odds of a transition from susceptible
to resistant as a function of DEC carriage and time. Models
were fit separately for each antibiotic. These logistic models were
formulated such that the odds of having a resistant isolate in
the current specimen is a function of having a resistant isolate
in the prior specimen and presence of pathogenic isolates in
the current or prior specimens, adjusting for known antibiotic
exposures (MDA or therapeutic amoxicillin or chloramphenicol),
and length of time (days) between specimen collection. MDA
exposure was defined as residence in a MDA village. Generalized
estimating equations with exchangeable correlation were used
to adjust for village-level clustering and robust standard errors
were calculated to account for residual within-person correlation
due to repeated measures (Liang and Zeger, 1986). Analyses
were performed using STATA 12 (StataCorp, College Station,
TX, USA).
RESULTS
We collected 1151 rectal swabs and 158 diarrheal stools from
377 individual children; 2492 E. coli isolates were recovered from
these specimens (Figure 1). The mean age of children included
in the E. coli sample was 1.13 years, average household size was
5.6 (standard deviation 2.1) people and 69.8% of participant
households had a latrine. On average, children contributed 6.6
isolates in total (range 1–18). Approximately 25% of isolates were
obtained from children reporting diarrheal symptoms (287 from
rectal swabs and 342 from diarrheal stools). Nearly half of the
children were MDA exposed (49.3%), 239 received therapeutic
amoxicillin, and 32 received therapeutic chloramphenicol.
The majority of E. coli isolated were non-pathogenic (72.4%);
439 (17.6%), 100 (4.0%), and 148 (5.9%) of isolates were identified
as EAEC, EPEC, and ETEC respectively. A total of 243 individual
children (64.5%) had ≥1 DEC type isolated during the study. In
cross-sectional survey specimens, ETEC and EAEC were detected
more frequently in isolates from symptomatic children (ETEC:
7.0 % vs. 4.3%, p = 0.045; EAEC: 23.0% vs. 17.7%, p = 0.030)
whereas there was no significant difference in EPEC detection
(4.2% vs. 3.7%, p = 0.658). Amongst isolates from diarrheal
stools, ETEC was identified most frequently (14.0%), followed by
EAEC (12.9%) and EPEC (5.9%).
The observed prevalence of resistance to six antibiotics
amongst pathogenic and non-pathogenic E. coli is shown in
Table 1. Resistance to AMP and SXT was most common amongst
isolates of all E. coli types. Resistance to these two antibiotics
was particularly high among pathogenic isolates with more than
80% of DEC isolates resistant to AMP and SXT. In contrast, CIP
resistance was rare, seen in only 15 isolates (all non-pathogenic).
The majority of isolates (75.9%) were resistant to ≥1 antibiotic
and 36.1% were multi-drug resistant. Multi-drug resistance was
common in EAEC (61%) and EPEC (42%) but less frequent
in ETEC (16.8%). Resistance to most of the antibiotics and
multi-drug resistance occurred more frequently in DEC isolates
(p ≤ 0.001). Resistance rates amongst pathogenic isolates from
diarrheal specimens were generally similar to rates amongst
pathogenic isolates from non-diarrheal specimens; the sole
exception was ERY resistance which was seen more frequently in
EPEC isolated from non-diarrheal specimens compared to EPEC
from diarrheal specimens (41.1% vs. 18.8%, p= 0.027).
A total of 177 fecal specimens yielded isolate sets that
enabled within specimen comparison of resistance status between
pathogenic and non-pathogenic isolates. We could not assess
CIP resistance concordance because no pathogenic isolates were
resistant. For all five antibiotics considered, the median odds of
resistance were greater for DEC isolates: median odds ratios (2.5,
97.5 percentiles) were 1.67 (1.25, 2.27) for AMC, 1.69 (1.45, 2.00)
for CHL, 1.95 (1.61, 2.33) for ERY, 2.22 (1.90, 2.71) for SXT,
and 2.72 (2.30, 3.33) for AMP (Supplementary Figure S1). The
associations between pathogenicity and resistance to AMP, SXT,
and ERY were highly significant with median p-values <0.025.
We assessed how DEC carriage affected within-person
temporal stability of resistance status (Table 2). Again, CIP
was excluded due to the low resistance frequency. Detection of
pathogenic isolates in the current fecal specimen was strongly
associated with current resistance to AMC, AMP, ERY, and
SXT (p < 0.02) whereas detection of pathogenic isolates in
the prior specimen was not statistically significantly associated
with current resistance to any antibiotic. Carriage of isolates
resistant to AMC, AMP, CHL or SXT in the prior specimen
was associated with increased odds of subsequent resistance;
the relationship was statistically significant for AMP and CHL
(p < 0.05). MDA exposure was significantly associated with
increased odds of carriage of isolates resistant to ERY (OR
3.64, p < 0.001) and SXT (OR 1.60, p < 0.05). A detailed
exploration of the impact of MDA on macrolide resistance has
been published previously (Seidman et al., 2014). Exposure to
therapeutic amoxicillin was not significantly associated with the
odds of resistance carriage for AMP or AMC; similarly, exposure
to therapeutic chloramphenicol was not associated with CHL
resistance status.
We observed 28 distinct antibiotic resistance phenotypes
using binary resistance categorization (Supplementary Table S2).
Resistance to both AMP and SXT was the most frequently
observed combination and was more common than resistance
to either antibiotic alone. Joint AMP/SXT resistance occurred in
12 of the 28 unique patterns. Resistance to CIP was seen only in
concert with resistance to other antibiotics. Two non-pathogenic
isolates were resistant to all 6 antibiotics tested.
DISCUSSION
We assessed resistance to six antibiotics in pathogenic and non-
pathogenic E. coli isolated from young children in rural Tanzania
over a 6-month period. We compared the resistance prevalence
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FIGURE 1 | Flow chart of specimen collection and E. coli isolation.
TABLE 1 | Antibiotic resistance prevalence (%) in pathogenic and non-pathogenic E. coli∗.
All isolates (N = 2492) Non-pathogenic (N = 1805) Pathogenic (N = 687) EAEC (N = 439) EPEC (N = 100) ETEC (N = 148)
AMC 10.6 9.2 14.4 16.4 15.0 8.1
AMP 65.1 59.1 80.9 82.9 79.0 76.4
CHL 14.3 12.0 20.5 26.7 9.0 10.1
CIP 0.6 0.8 0 0 0 0
ERY 29.4 27.2 35.4 45.3 34.0 6.8
SXT 68.3 63.1 82.0 87.5 79.0 67.6
≥3 antibiotics 36.1 31.3 48.8 61.0 42.0 16.8
∗Chi-squared tests for differences in frequency of resistance comparing pathogenic and non-pathogenic isolates statistically significant (p < 0.001) for all antibiotics and
multi-drug resistance.
TABLE 2 | Logistic regression models to assess the temporal relationship between carriage of antibiotic resistance and pathogenic E. coli.
AMC AMP CHL ERY SXT
Resistant isolates in previous specimen 1.36 (0.84, 2.21) 1.40 (1.05, 1.86)∗ 1.65 (1.02, 2.69) ∗ 0.99 (0.58, 1.70) 1.32 (0.99, 1.76)
Pathogenic isolates in current specimen 1.76 (1.10, 2.80)∗ 4.52 (3.78, 5.42)∗∗∗ 1.79 (0.88, 3.68) 1.73 (1.10, 2.72)∗ 3.18 (1.59, 6.38)∗∗
Pathogenic isolates in previous specimen 0.92 (0.63, 1.36) 0.81 (0.48, 1.36) 1.16 (0.82, 1.65) 1.00 (0.77, 1.29) 0.86 (0.69, 1.07)
Exposure to MDA 1.30 (0.82, 2.06) 1.64 (0.91, 2.94) 0.93 (0.62, 1.39) 3.64 (2.38, 5.78)∗∗∗ 1.60 (1.09, 2.35)∗
Treatment with antibiotics since last specimen 1.00 (0.76, 1.32)† 0.79 (0.58, 1.07)† 1.06 (0.53, 2.12)§
Days between previous specimen and current specimen 0.99 (0.99, 0.99)∗∗∗ 1.00 (0.99, 1.01) 1.00 (0.99, 1.01) 0.99 (0.98, 1.00) 0.99 (0.98, 1.01)
Odds ratios and 95% CI for ever positive. p-values indicated as : ∗ < 0.05, ∗∗ < 0.01, ∗∗∗ < 0.001. †Exposure to amoxicillin. §Exposure to chloramphenicol.
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by pathogenic type in the population of isolates as well as within
individual children over time. Three quarters of isolates were
resistant to ≥1 antibiotic and more than 30% were multi-drug
resistant. Overall, AMP and SXT resistance was highly prevalent
while CIP resistance was rare. These findings were similar to
prior studies of E. coli resistance in African sites although a more
recent study in Ghanaian adults reported much higher levels of
quinolone resistance than we observed in our study (Nys et al.,
2004; Djie-Maletz et al., 2008; Moyo et al., 2011; Namboodiri
et al., 2011).
Approximately 30% of the E. coli isolated were ETEC, EPEC,
or EAEC and resistance to 5 of 6 antibiotics occurred significantly
more frequently in DEC isolates compared to non-pathogenic
isolates. In contrast, a study in young Brazilian children found
no differences in AMP and SXT resistance prevalence between
pathogenic and non-pathogenic E. coli (Garcia et al., 2011). The
high prevalence of resistance in the DEC strains we observed is
in keeping with a previous Tanzanian study where prevalence
of resistance in ETEC, EAEC and EPEC isolated from pediatric
diarrhea cases was very high for AMP (83–90%), CHL (25–57%),
and SXT (79–90%) (Vila et al., 1999).
Diarrheagenic E. coli were approximately twice as likely to
be resistant to ERY, AMP, or SXT compared to non-pathogenic
isolates from the same fecal specimen. We were unable to find
other examples in the literature of within-person comparison
of resistance phenotypes between E. coli pathotypes, however,
some studies have found evidence for genetic linkages between
resistance genes and virulence factors in E. coli isolated from
swine (Boerlin et al., 2005; Lay et al., 2012).
At the person level, detection of AMP-, SXT-, or CHL-resistant
isolates at a previous sampling time increased the odds of
subsequent resistance carriage. We expected that prior resistance
status would be the most significant predictor of current status,
hypothesizing that once resistance was established within an
individual, it would be sustained. However, although resistance
status at the previous time point was associated with current
status, isolation of DEC strains from the current specimen was a
greater predictor of current resistance status for AMC, AMP, ERY,
and SXT than status at the previous time point. While resistance
was maintained within individuals, this may reflect continual
acquisition of resistant strains from the environment rather than
long-term carriage of a clonal strain. A study in adults returning
to Australia following international travel did find a high rate of
clonal carriage of resistant E. coli for 2 months or longer, however,
the risk of environmental exposures and frequency of acquisition
of resistant strains may be considerably lower in adults living in
Australia compared to our study population of young children
in rural Tanzania (Rogers et al., 2012). It is a limitation of our
study that we could not distinguish between long-term carriage
of resistant strains versus new colonization with phenotypically
similar strains.
Direct exposure to antibiotic therapy is thought to a major
driver of resistance. In our study, MDA exposure was highly
associated with increased ERY resistance but exposure to
therapeutic amoxicillin and chloramphenicol was not associated
with subsequent AMP or CHL resistance carriage. Studies of
post-MDA macrolide resistance in S. pneumoniae have found a
range of resistance levels from 0 to 82% (Leach et al., 1997; Fry
et al., 2002; Haug et al., 2010; Coles et al., 2013). Previously we
showed previously that macrolide resistance in E. coli increased
significantly following MDA then tapered over the subsequent
6-month period, although it remained elevated above baseline
levels (Seidman et al., 2014). In the four treatment villages, the
entire community was treated simultaneously during MDA, thus
the selective pressure on the bacterial community was substantial.
In contrast, in both intervention and control villages, therapeutic
antibiotics were given to individuals at different times and likely
did not affect the bacterial population in the same way. Prior
studies have shown a relationship between recent therapeutic
antibiotic use and carriage of resistant E. coli, but the effects
may be short lived (Stürmer et al., 2004; Lietzau et al., 2007;
Samore et al., 2011). In our study, the time between antibiotic
therapy and specimen collection varied, which may have limited
our ability to detect transient increases in resistance. Since AMP
resistance carriage was already highly prevalent at baseline, the
impact of amoxicillin therapy on the development of AMP
resistance may have been difficult to observe. We chose to assess
resistance to commonly used, locally available antibiotics, thus we
did not characterize the prevalence of cephalosporin resistance;
this would be a valuable area for future research as extended-
spectrum beta-lactamases become more wide-spread in around
the world (Woerther et al., 2013).
We found significant within-person heterogeneity in
resistance status over time. Since we were only able to test up
to three isolates per fecal specimen and our multiplex PCR
assay detected only three pathogenic types of DEC, we may
not have sampled the full heterogeneity of resistance patterns
within individual specimens and some isolates we considered
non-pathogenic may have been DEC pathotypes not detected
by our assay. Previous studies of DEC in Tanzania found EAEC,
EPEC, and ETEC to be most common; studies screening for more
DEC types have detected enterohemorrhagic and enteroinvasive
E. coli at very low frequencies (Vila et al., 1999; Gascon et al.,
2000; Vargas et al., 2004; Moyo et al., 2007). We did not identify
genes encoding resistance. However, given that our results
showed a higher prevalence of resistance among DEC strains,
it is crucial that future studies evaluate differences in resistance
mechanisms between pathogenic and non-pathogenic E. coli as
well as characterize the mobility of these genetic elements to
understand transmission within the microbial community.
We found significant antibiotic resistance levels in pathogenic
E. coli isolated from young Tanzanian children. Specific multi-
drug resistance phenotypes were common to both pathogenic
and non-pathogenic strains, indicating that commensal E. coli
can serve as a sentinel organism for patterns in circulating
pathogenic strains. Resistance was more frequent in DEC isolates
compared to non-pathogenic isolates at both individual and
population scales. The potential linkage between resistance
genes and virulence determinants underscores the urgent
need for a renewed focus on implementation of sanitation
and hygiene interventions in low-income countries. Children
in these settings are continuously exposed enteropathogens
from contaminated home environments (Mattioli et al., 2014).
Sanitation interventions may serve a dual purpose in limiting
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both enteric infection and an environmental reservoir of
antimicrobial resistance thus mitigating the burden of a
significant proportion of several pediatric infectious diseases.
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